Remus Pharmaceuticals Appoints Mr. Bhavik Shah as Chief Financial Officer
Remus Pharmaceuticals Limited has appointed Mr. Bhavik Shah as the new Chief Financial Officer (CFO) and Key Managerial Personnel of the company. The appointment is effective starting July 09, 2026.The selection of Mr. Bhavik Shah was made by the Board of Directors, based on the recommendation of the Nomination and Remuneration Committee and approval from the Audit Committee.
Mr. Shah brings extensive experience to the role. He is a Chartered Accountant and Commerce Graduate with over two decades of experience across various financial functions. His expertise covers Finance, Accounts, Treasury, Financial Reporting, Budgeting, Taxation, Audit, Internal Controls, and Regulatory Compliance.
His professional background includes significant work in:
- Financial reporting under Ind AS and IFRS.
- Business planning and working capital management.
- Treasury operations and profitability analysis.
- Costing and ERP implementation.
Mr. Shah has held leadership positions in reputed organizations across multiple sectors, including the healthcare and pharmaceuticals industries. His background emphasizes strengthening financial controls, enhancing business performance, and supporting strategic decision-making.
REMUS Stock Price Movement
Remus Pharmaceuticals Limited shares closed today, gaining 1.88% to settle at ₹797.15 after steady trading in the market. The stock traded within an intraday range of ₹790.05 to ₹800, with a recorded volume of 2,500 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.